CUSIP 230031106COMCGEMQ4 2025
40 filings · latest Mar 4, 2026
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Lynx1 Capital Management LP | 8.96M | $92.77M |
| 2 | Mpm Bioimpact LLC | 7.65M | $79.16M |
| 3 | Bvf Inc/Il | 5.75M | $59.52M |
| 4 | Blackrock, Inc. | 4.40M | $45.54M |
| 5 | Vanguard Group Inc | 3.30M | $34.14M |
| 6 | Kynam Capital Management, LP | 3.11M | $32.23M |
| 7 | Blue Owl Capital Holdings LP | 2.35M | $24.33M |
| 8 | State Street Corp | 2.20M | $22.74M |
| 9 | Affinity Asset Advisors, LLC |
| 4 | Nov 14, 2025 | Citadel Advisors LLC | 13G/A | 3.4% | 1.99M | SEC |
| 5 | Nov 14, 2025 | Lynx1 Capital Management LP | 13G/A | 9.8% | 5.77M | SEC |
| 6 | Nov 13, 2025 | Deerfield Mgmt, L.P. | 13G/A | 5.0% | 2.93M | SEC |
| 7 | Oct 30, 2025 | The Vanguard Group | 13G/A | 5.0% | 2.94M | SEC |
| 8 | Oct 10, 2025 | Lynx1 Capital Management LP | 13G/A | 14.5% | 8.55M | SEC |
| 9 | Aug 14, 2025 | Lynx1 Capital Management LP | 13G | 7.5% | 4.40M | SEC |
| 10 | Aug 6, 2025 | Citadel Advisors LLC | 13G | 5.1% | 3.01M | SEC |
See the full Schedule 13D/13G history for Cullinan Therapeutics Inc.
Unlock full history| 1.93M |
| $20.00M |
| 10 | Rtw Investments, LP | 1.71M | $17.66M |